The table below shows Olema Pharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$146.72M
-$104.35M
-$83.73M
-$82.06M
-$50.69M
-$19.87M
Capital expenditure
-
$159.00K
-
$363.00K
$1.57M
$56.00K
Investing cash flow
-$155.76M
-$93.53M
-$4.85M
$91.48M
-$275.44M
-$56.00K
Dividends paid
-
-
-
-
OLMA operating cash flow (10-K history)
Olema Pharmaceuticals, Inc. reported operating cash flow of -$146.72M for fiscal year 2025. That is down 40.6% from -$104.35M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$3.08M (FY 2019) to -$146.72M. Figures come from the company's audited annual reports as filed with the SEC.